The Cytogenetics of Hematologic Neoplasms 1 5

Total Page:16

File Type:pdf, Size:1020Kb

The Cytogenetics of Hematologic Neoplasms 1 5 The Cytogenetics of Hematologic Neoplasms 1 5 Aurelia Meloni-Ehrig that errors during cell division were the basis for neoplastic Introduction growth was most likely the determining factor that inspired early researchers to take a better look at the genetics of the The knowledge that cancer is a malignant form of uncon- cell itself. Thus, the need to have cell preparations good trolled growth has existed for over a century. Several biologi- enough to be able to understand the mechanism of cell cal, chemical, and physical agents have been implicated in division became of critical importance. cancer causation. However, the mechanisms responsible for About 50 years after Boveri’s chromosome theory, the this uninhibited proliferation, following the initial insult(s), fi rst manuscripts on the chromosome makeup in normal are still object of intense investigation. human cells and in genetic disorders started to appear, fol- The fi rst documented studies of cancer were performed lowed by those describing chromosome changes in neoplas- over a century ago on domestic animals. At that time, the tic cells. A milestone of this investigation occurred in 1960 lack of both theoretical and technological knowledge with the publication of the fi rst article by Nowell and impaired the formulations of conclusions about cancer, other Hungerford on the association of chronic myelogenous leu- than the visible presence of new growth, thus the term neo- kemia with a small size chromosome, known today as the plasm (from the Greek neo = new and plasma = growth). In Philadelphia (Ph) chromosome, to honor the city where it the early 1900s, the fundamental role of chromosomes in was discovered (see also Chap. 1 ) [ 4 ] . This fi nding stimu- heredity and reproduction was already valued by a number of lated subsequent research on chromosome aberrations in biologists. During that period, the most comprehensive view human neoplasms that still continues to augment our under- of the role played by chromosomes in heredity was held by standing about cancer. This chapter will focus on the visibly Boveri and Sutton, who independently theorized that it was recognizable chromosome abnormalities in human hemato- necessary to have all chromosomes present in the cells for logic neoplasms and their implication in diagnosis, prognosis, proper embryonic development to take place [1, 2 ] . This and therapeutic strategies. innovative concept was later applied to the origin of tumor cells by Boveri himself. Although he never experimented with tumors, Boveri obviously sensed that tumors began Cytogenetic Methods for Diagnosis from a single cell in which defects in the chromosome of Hematologic Neoplasms makeup led cells to divide uncontrollably. He formulated his theories in the book Zur Frage der Entstehung maligner Cytogenetics requires the presence of live cells or at least Tumoren (On the Problem of Origin of Malignant Tumors), intact nuclei (for FISH studies; see Chap. 17 ). Although it is published in 1914 [ 3 ] . This book is probably the most impor- understood that human cancer cells divide spontaneously tant early contribution on the genetics of cancer, as it offered and that culturing might not be a necessary step, it is also true some of the concepts still applicable today, speci fi cally that that neoplastic cells are regulated by different growth cycles, chromosome imbalances, mitotic disturbance, and monoclo- and therefore longer times in culture, as well as mitogen nality are all attributes found in cancer cells. The thought stimulation (in the case of mature lymphoid neoplasms), may be bene fi cial [ 5– 8 ] . Cytogenetics starts with proper sample collection, which in the case of hematologic neoplasms A. Meloni-Ehrig , Ph.D., D.Sc. (*) includes bone marrow aspirate, peripheral blood, as well as Department of Cytogenetics , Ameripath Central Florida, 8150 Chancellor Drive, Suite 110 Orlando, FL, USA various body fl uids and solid tissues in which in fi ltration e-mail: [email protected] by the neoplastic hematologic cells has occurred [ 5, 9 ] . S.L. Gersen and M.B. Keagle (eds.), The Principles of Clinical Cytogenetics, Third Edition, 309 DOI 10.1007/978-1-4419-1688-4_15, © Springer Science+Business Media New York 2013 310 A. Meloni-Ehrig Fig. 15.1 G-banded karyogram of a normal bone marrow cell Collection of samples should be performed aseptically, and in various tissue preparations. Their invention was seen as a the case of solid tissues, samples should be placed in a room potential competitor to conventional cytogenetics, due to their temperature medium, preferably enriched with growth higher resolution. Nevertheless, several years after the intro- factors and antibiotics. Longer transit times (>48 h) might duction of these sophisticated technologies, conventional affect the viability of the neoplastic cells and should be cytogenetic analysis is still the best method for the diagnosis avoided when possible [ 5 ] . Analyzable chromosome prepa- of most hematologic neoplasms since it has the advantage rations are obtained by fi rst exposing the cells to mitotic of an overall examination of all chromosomes, compared to inhibitors and subsequently treating them with hypotonic the more focused detection of abnormalities with the other solution and fi xation [ 10, 11 ] . Chromosome preparations are molecular genetic methods. Undisputed, in fact, is the ability then subjected to banding techniques, the most widespread of conventional cytogenetics to identify related and distinct of which is the trypsin-Giemsa banding method [ 12, 13 ] . See clonal populations, which is challenging for FISH and practi- Fig. 15.1 ; see also Chap. 4 . The terms used in cancer cytoge- cally impossible for array CGH [24, 25 ] . Furthermore, the netics are listed in Table 15.1 , and the karyotypes are presence of abnormalities acquired during clonal evolution, described according to An International System for Human an important indicator of disease progression, might be Cytogenetic Nomenclature (the most recent version appeared missed during a targeted FISH analysis [26– 29 ] . in 2009; see also Chap. 3 ) [ 14 ] . Chromosome Abnormalities in Hematologic Importance of Conventional Cytogenetics in Neoplasms the Diagnosis and Prognosis of Hematologic Neoplasms Cytogenetics began in 1956, when Tijo and Levan, and soon after them Ford and Hamerton declared that normal human There is no question that the development of sophisticated cells contained 46 chromosomes and not 48, as previously techniques such as fl uorescence in situ hybridization (FISH), believed (see Chap. 1 ) [ 30, 31 ] . From that point on, experi- multicolor karyotyping (M-FISH, SKY), and, to some extent, mental work on cell cultures and banding was geared to the array comparative genomic hybridization (array CGH) has improvement of chromosome spreading and morphology and enhanced the knowledge of chromosome abnormalities in was presented in subsequent publications [ 4, 32 ] . It was the hematologic neoplasms [15– 23 ] (see also Chaps. 17 and 18 ). detection of the Philadelphia chromosome by Nowell and These techniques have immensely contributed to the discov- Hungerford, however, that de fi nitively established that chro- ery of signi fi cant cryptic rearrangements as well as to the mosome abnormalities in leukemia are acquired and as such detection of such rearrangements in nondividing cells of they are present exclusively in the neoplastic cells [4 ] . But it 15 The Cytogenetics of Hematologic Neoplasms 311 Table 15.1 Glossary of cytogenetics terminology used in this chapter Acentric fragment A chromosome fragment lacking a centromere and therefore incapable of attaching to the spindle. Acentric chromosomes are distributed randomly among daughter cells Aneuploidy Deviation of the chromosome number that is characteristic for a particular species caused by either gain or loss of one or more chromosomes Autosome Any chromosome other than the sex chromosomes Banding Alternating intrachromosomal light and dark segments along the length of chromosomes Breakpoint Speci fi c band on a chromosome containing a break in the DNA as the result of a chromosome rearrangement Centromere An area of chromosomal constriction that holds the two chromatids together and is needed for spindle site attachment. Based on the position of the centromere, chromosomes are classi fi ed as metacentric (middle position), submetacentric (above the middle), and acrocentric (extremely small short arm consisting of satellites and stalks) Chromosome Arrangement of nuclear genetic material into formations containing a centromere and two chromosome arms. The normal chromosome number in human somatic cells is 46, whereas in germ cells it is 23 Chromosome rearrangement Structural aberration in which chromosomes are broken and rejoined. These rearrangements can occur on a single chromosome or involve multiple chromosomes Clonal evolution A stepwise evolution characterized by the acquisition of new cytogenetic abnormalities Cytogenetics The examination of chromosomes Deletion Loss of a chromosome segment. Deletions can either be terminal or interstitial Dicentric A chromosome containing two centromeres Diploid Normal chromosome complement (two copies of each autosome and two sex chromosomes) in somatic cells Double minute Cytogenetic visualization of gene ampli fi cation. So called because of their appearance as two adjacent dots. Each double minute is thought to contain hundreds of copies of a particular oncogene Duplication Two copies of the same segment present
Recommended publications
  • Preimplantation Genetic Diagnosis (PGD)
    Preimplantation Genetic Diagnosis (PGD) AS3323/5621 Lecture 7 Sept 19, 2017 1 Risks of Fetal Loss A total of 634,272 women and 1,221,546 pregnancy outcomes in Denmark from 1978 to 1992. 2 Anderson et al. BMJ, 2000,320:1708-1712. Meiotic Non-disjunction:% Trisomy? 3 Aneuploidy P centromere Q Abnormal number of chromosomes in a cell. 4 Aneuploidy: the most common cause for early pregnancy failure Prevalence of oocyte and embryo aneuploidy increases with maternal age Also increase in chromosomally normal couples with recurrent early pregnancy loss or repeated failed IVF cycles despite the transfer of high-quality embryos (based on morphology). http://www.asrm.org/uploadedFiles/ASRM_Content/News_and_Publications/Practice_Guidelines/Commi ttee_Opinions/Preimplantation_genetic_testing(1).pdf 5 “Common” Types of Trisomy Trisomy 21 – Down’s Syndrome karyotype 47, XX +21 or 47, XY + 21 frequency ~ 1/600 births Trisomy 18 – Edward’s Syndrome karyotype 47, XX + 18 or 47, XY + 18 Frequency ~ 1 in 10,000 births Sex chromosome trisomies 47, XXY (Klinefelter Syndrome), 1/1,000 males 47, XXX (super females), many un-diagnosed Polysomy X e.g., XXXX Trisomies of other chromosomes partial, mosaic and rare incompatible with life 6 Monosomy • No other live births of full monosomy – abortion • Cancer cells (lymphocytes) • Only partial monosomies in live births • Turner’s Syndrome: XO females 7 Why does aneuploidy lead to fetal death? Gene dosage • Intolerance to deviations from diploid • Extra or missing chromosomes causes developmental defects and/or death (monosomy, trisomy) • Sex chromosomes exception • On the surface 8 Central Dogma of Gene Expression 9 http://cnx.org/contents/Z7qBU2RZ@5/The-Central-Dogma-and-Basic-Tr Gene copy number vs.
    [Show full text]
  • (APOCI, -C2, and -E and LDLR) and the Genes C3, PEPD, and GPI (Whole-Arm Translocation/Somatic Cell Hybrids/Genomic Clones/Gene Family/Atherosclerosis) A
    Proc. Natl. Acad. Sci. USA Vol. 83, pp. 3929-3933, June 1986 Genetics Regional mapping of human chromosome 19: Organization of genes for plasma lipid transport (APOCI, -C2, and -E and LDLR) and the genes C3, PEPD, and GPI (whole-arm translocation/somatic cell hybrids/genomic clones/gene family/atherosclerosis) A. J. LUSIS*t, C. HEINZMANN*, R. S. SPARKES*, J. SCOTTt, T. J. KNOTTt, R. GELLER§, M. C. SPARKES*, AND T. MOHANDAS§ *Departments of Medicine and Microbiology, University of California School of Medicine, Center for the Health Sciences, Los Angeles, CA 90024; tMolecular Medicine, Medical Research Council Clinical Research Centre, Harrow, Middlesex HA1 3UJ, United Kingdom; and §Department of Pediatrics, Harbor Medical Center, Torrance, CA 90509 Communicated by Richard E. Dickerson, February 6, 1986 ABSTRACT We report the regional mapping of human from defects in the expression of the low density lipoprotein chromosome 19 genes for three apolipoproteins and a lipopro- (LDL) receptor and is strongly correlated with atheroscle- tein receptor as well as genes for three other markers. The rosis (15). Another relatively common dyslipoproteinemia, regional mapping was made possible by the use of a reciprocal type III hyperlipoproteinemia, is associated with a structural whole-arm translocation between the long arm of chromosome variation of apolipoprotein E (apoE) (16). Also, a variety of 19 and the short arm of chromosome 1. Examination of three rare apolipoprotein deficiencies result in gross perturbations separate somatic cell hybrids containing the long arm but not of plasma lipid transport; for example, apoCII deficiency the short arm of chromosome 19 indicated that the genes for results in high fasting levels oftriacylglycerol (17).
    [Show full text]
  • IRF4/DUSP22 Gene Rearrangement by FISH
    IRF4/DUSP22 Gene Rearrangement by FISH The IRF4/DUSP22 locus is rearranged in a newly recognized subtype of non-Hodgkin lymphoma, large B-cell lymphoma with IRF4 rearrangement. These lymphomas are uncommon, but are clinically distinct from morphologically similar lymphomas, Tests to Consider including diffuse large B-cell lymphoma, high-grade follicular lymphoma, and pediatric- type follicular lymphoma. The IRF4/DUSP22 locus is also rearranged in a subset of ALK- IRF4/DUSP22 (6p25) Gene Rearrangement negative anaplastic large cell lymphomas (ALCL), where this rearrangement is associated by FISH 3001568 with a signicantly better prognosis. Method: Fluorescence in situ Hybridization (FISH) Test is useful in identifying ALK-negative anaplastic large cell lymphomas and large B- Disease Overview cell lymphoma with IRF4 rearrangement The rearrangement is associated with an improved prognosis Incidence See Related Tests Large B-cell lymphoma with IRF4 rearrangement accounts for <1% of all non-Hodgkin B-cell lymphomas overall More common in younger patients, with an incidence of 5-6% under age 18 IRF4/DUSP22 rearrangement is found in 30% of ALK-negative ALCLs Symptoms/Findings Large B-cell lymphoma with IRF4 rearrangement typically presents with limited stage disease in the head and neck, while the presentation of ALK-negative ALCLs is variable. Disease-Oriented Information Patients with large B-cell lymphoma with IRF4 rearrangement typically have a favorable outcome after treatment. Rearrangement of the IRF4/DUSP22 locus in ALK-negative ALCL is associated with a better prognosis than ALK-negative ALCL without this rearrangement. Test Interpretation Analytical Sensitivity The limit of detection (LOD) for the IRF4/DUSP22 probe was established by calculating the upper limit of the abnormal signal pattern in normal cells using the Microsoft Excel BETAINV function.
    [Show full text]
  • Clinical Outcome in Pediatric Patients with Philadelphia Chromosome
    cancers Article Clinical Outcome in Pediatric Patients with Philadelphia Chromosome Positive ALL Treated with Tyrosine Kinase Inhibitors Plus Chemotherapy—The Experience of a Polish Pediatric Leukemia and Lymphoma Study Group Joanna Zawitkowska 1,*, Monika Lejman 2 , Marcin Płonowski 3, Joanna Bulsa 4, Tomasz Szczepa ´nski 4 , Michał Romiszewski 5, Agnieszka Mizia-Malarz 6, Katarzyna Derwich 7, Gra˙zynaKarolczyk 8, Tomasz Ociepa 9, Magdalena Cwikli´ ´nska 10, Joanna Treli´nska 11, Joanna Owoc-Lempach 12, Ninela Irga-Jaworska 13, Anna Małecka 13, Katarzyna Machnik 14, Justyna Urba ´nska-Rakus 14, Radosław Chaber 15 , Jerzy Kowalczyk 1 and Wojciech Młynarski 11 1 Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, 20-059 Lublin, Poland; [email protected] 2 Laboratory of Genetic Diagnostics, Medical University of Lublin, 20-059 Lublin, Poland; [email protected] 3 Department of Pediatric Oncology, Hematology, Medical University of Bialystok, 15-089 Bialystok, Poland; [email protected] 4 Department of Pediatrics, Hematology and Oncology, Medical University of Silesia, 40-752 Katowice, Poland; [email protected] (J.B.); [email protected] (T.S.) 5 Department of Hematology and Pediatrics, Medical University of Warsaw, 02-091 Warsaw, Poland; [email protected] 6 Department of Pediatric Oncology, Hematology and Chemotherapy, Medical University of Silesia, 40-752 Katowice, Poland; [email protected] 7 Department of Pediatric Oncology, Hematology and
    [Show full text]
  • Follicular Lymphoma
    Follicular Lymphoma What is follicular lymphoma? Let us explain it to you. www.anticancerfund.org www.esmo.org ESMO/ACF Patient Guide Series based on the ESMO Clinical Practice Guidelines FOLLICULAR LYMPHOMA: A GUIDE FOR PATIENTS PATIENT INFORMATION BASED ON ESMO CLINICAL PRACTICE GUIDELINES This guide for patients has been prepared by the Anticancer Fund as a service to patients, to help patients and their relatives better understand the nature of follicular lymphoma and appreciate the best treatment choices available according to the subtype of follicular lymphoma. We recommend that patients ask their doctors about what tests or types of treatments are needed for their type and stage of disease. The medical information described in this document is based on the clinical practice guidelines of the European Society for Medical Oncology (ESMO) for the management of newly diagnosed and relapsed follicular lymphoma. This guide for patients has been produced in collaboration with ESMO and is disseminated with the permission of ESMO. It has been written by a medical doctor and reviewed by two oncologists from ESMO including the lead author of the clinical practice guidelines for professionals, as well as two oncology nurses from the European Oncology Nursing Society (EONS). It has also been reviewed by patient representatives from ESMO’s Cancer Patient Working Group. More information about the Anticancer Fund: www.anticancerfund.org More information about the European Society for Medical Oncology: www.esmo.org For words marked with an asterisk, a definition is provided at the end of the document. Follicular Lymphoma: a guide for patients - Information based on ESMO Clinical Practice Guidelines – v.2014.1 Page 1 This document is provided by the Anticancer Fund with the permission of ESMO.
    [Show full text]
  • Ring Chromosome 4 49,XXXXY Patients Is Related to the Age of the Mother
    228 Case reports placenta and chorionic sacs were of no help for Further cytogenetic studies in twins would be diagnosis. The dermatoglyphs are expected to be necessary to find out whether there is a relation different, even ifthey were monozygotic, in relation to between non-disjunction and double ovulation or the total finger ridge count; since according to whether these 2 events are independent but could Penrose (1967), when the number of X chromosomes occur at the same time by chance. increases, the TFRC decreases in about 30 per each extra X. The difference of 112 found in our case is so We want to thank Dr Maroto and Dr Rodriguez- striking that we believe that we are facing a case of Durantez for performing the cardiological and dizygosity. On the other hand, the blood groups were radiological studies; Dr A. Valls for performing the conclusive. All the systems studied were alike in Xg blood group. We also wish to thank Mrs A. both twins except for the Rh. In the propositus the Moran and Mrs M. C. Cacituaga for their technical phenotype was CCDee while in the brother it was assistance. cCDee, which rules out monozygosity. The incidence of dizygotic twins with noncon- J. M. GARCIA-SAGREDO, C. MERELLO-GODINO, cordant chromosomal aneuploidy appears to be low. and C. SAN ROMAN To the best of our knowledge we think that ours is the From the Department ofHuman Genetics, first reported case of dizygotic twins with this specific Fundacion Jimenez Diaz, Madrid; and anomaly. U.C.I., Hospital Infantil, C.S.
    [Show full text]
  • The Lymphoma and Multiple Myeloma Center
    The Lymphoma and Multiple Myeloma Center What Sets Us Apart We provide multidisciplinary • Experienced, nationally and internationally recognized physicians dedicated exclusively to treating patients with lymphoid treatment for optimal survival or plasma cell malignancies and quality of life for patients • Cellular therapies such as Chimeric Antigen T-Cell (CAR T) therapy for relapsed/refractory disease with all types and stages of • Specialized diagnostic laboratories—flow cytometry, cytogenetics, and molecular diagnostic facilities—focusing on the latest testing lymphoma, chronic lymphocytic that identifies patients with high-risk lymphoid malignancies or plasma cell dyscrasias, which require more aggresive treatment leukemia, multiple myeloma and • Novel targeted therapies or intensified regimens based on the other plasma cell disorders. cancer’s genetic and molecular profile • Transplant & Cellular Therapy program ranked among the top 10% nationally in patient outcomes for allogeneic transplant • Clinical trials that offer tomorrow’s treatments today www.roswellpark.org/partners-in-practice Partners In Practice medical information for physicians by physicians We want to give every patient their very best chance for cure, and that means choosing Roswell Park Pathology—Taking the best and Diagnosis to a New Level “ optimal front-line Lymphoma and myeloma are a diverse and heterogeneous group of treatment.” malignancies. Lymphoid malignancy classification currently includes nearly 60 different variants, each with distinct pathophysiology, clinical behavior, response to treatment and prognosis. Our diagnostic approach in hematopathology includes the comprehensive examination of lymph node, bone marrow, blood and other extranodal and extramedullary tissue samples, and integrates clinical and diagnostic information, using a complex array of diagnostics from the following support laboratories: • Bone marrow laboratory — Francisco J.
    [Show full text]
  • Philadelphia Chromosome Unmasked As a Secondary Genetic Change in Acute Myeloid Leukemia on Imatinib Treatment
    Letters to the Editor 2050 The ELL/MLLT1 dual-color assay described herein entails 3Department of Cytogenetics, City of Hope National Medical Center, Duarte, CA, USA and co-hybridization of probes for the ELL and MLLT1 gene regions, 4 each labeled in a different fluorochrome to allow differentiation Cytogenetics Laboratory, Seattle Cancer Care Alliance, between genes involved in 11q;19p chromosome translocations Seattle, WA, USA E-mail: [email protected] in interphase or metaphase cells. In t(11;19) acute leukemia cases, gain of a signal easily pinpoints the specific translocation breakpoint to either 19p13.1 or 19p13.3 and 11q23. In the References re-evaluation of our own cases in light of the FISH data, the 19p breakpoints were re-assigned in two patients, underscoring a 1 Harrison CJ, Mazzullo H, Cheung KL, Gerrard G, Jalali GR, Mehta A certain degree of difficulty in determining the precise 19p et al. Cytogenetic of multiple myeloma: interpretation of fluorescence in situ hybridization results. Br J Haematol 2003; 120: 944–952. breakpoint in acute leukemia specimens in the context of a 2 Thirman MJ, Levitan DA, Kobayashi H, Simon MC, Rowley JD. clinical cytogenetics laboratory. Furthermore, we speculate that Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) the ELL/MLLT1 probe set should detect other 19p translocations in acute myeloid leukemia. Proc Natl Acad Sci 1994; 91: 12110– that involve these genes with partners other than MLL. Accurate 12114. molecular classification of leukemia is becoming more im- 3 Tkachuk DC, Kohler S, Cleary ML.
    [Show full text]
  • Low-Grade Non-Hodgkin Lymphoma Book
    Low-grade non-Hodgkin lymphoma Low-grade non-Hodgkin lymphoma Follicular lymphoma Mantle cell lymphoma Marginal zone lymphomas Lymphoplasmacytic lymphoma Waldenström’s macroglobulinaemia This book has been researched and written for you by Lymphoma Action, the only UK charity dedicated to people affected by lymphoma. We could not continue to support you, your clinical team and the wider lymphoma community, without the generous donations of our incredible supporters. As an organisation we do not receive any government or NHS funding and so every penny received is truly valued. To make a donation towards our work, please visit lymphoma-action.org.uk/Donate 2 Your lymphoma type and stage Your treatment Key contact Name: Role: Contact details: Job title/role Name and contact details GP Consultant haematologist/ oncologist Clinical nurse specialist or key worker Treatment centre 3 About this book Low-grade (or indolent) non-Hodgkin lymphoma is a type of blood cancer that develops from white blood cells called lymphocytes. It is a broad term that includes lots of different types of lymphoma. This book explains what low-grade non-Hodgkin lymphoma is and how it is diagnosed and treated. It includes tips on coping with treatment and dealing with day-to-day life. The book is split into chapters. You can dip in and out of it and read the sections that are relevant to you at any given time. Important and summary points are written in the chapter colour. Lists practical tips and chapter summaries. Gives space for questions and notes. Lists other resources you might find useful, some of which are online.
    [Show full text]
  • Pathogenetics. an Introductory Review
    The Egyptian Journal of Medical Human Genetics (2016) 17, 1–23 HOSTED BY Ain Shams University The Egyptian Journal of Medical Human Genetics www.ejmhg.eg.net www.sciencedirect.com REVIEW Pathogenetics. An introductory review Mohammad Saad Zaghloul Salem 1 Faculty of Medicine, Ain-Shams University, Cairo, Egypt Received 1 July 2015; accepted 7 July 2015 Available online 27 July 2015 KEYWORDS Abstract Pathogenetics refers to studying the different aspects of initiation/development/progres Pathogenetics; sion and pathogenesis of genetic defects. It comprises the study of mutagens or factors capable Mutagens; of affecting the structural integrity of the genetic material leading to mutational changes that, in Mutation; the majority of cases, result in harmful effects due to the resulting disturbances of functions of Pathogenetic mechanisms; mutated components of the genome. The study of mutagens depicts different types of mutagenic Anti-mutation mechanisms factors, their nature, their classification according to their effects on the genetic material and their different modes of action. The study of mutation involves different types of mutations classified according to various parameters, e.g. magnitude, severity, target of mutational event as well as its nature, which can be classified, in turn, according to whether it is spontaneous or induced, static or dynamic, somatic or germinal mutation etc. Finally, pathogenetics comprises studying and delin- eating the different and innumerable pathophysiological alterations and pathogenetic mechanisms that are directly and indirectly involved in, and leading to, the development of genetic disorders, coupled with a parallel study of various anti-mutation mechanisms that play critical roles in minimizing the drastic effects of mutational events on the genetic material and in effective protection against the development of these diseases.
    [Show full text]
  • But Broke Down More Frequently Than Those Stabilised by Natural Degree
    HYBRIDITY SELECTION IN CAMPANULA C. D. DARLINGTON and L. F. LA COUR John Innes Horticultural Institution, Bayfordbury, Hert ford, Herts. Received25.Viii.49 CONTENTS I. Introduction . .217 2. Building Newlypes . .218 3. Ring-Formation and the Hybridity Optimum . .219 4. Analytic Crosses . .222 5. Unbalanced Types . .224 6. Fertility and the Breeding System . .226 7. New Interchanges . .227 8. The Stable Telocentric . .228 9. Telocentrics and Interchanges . 230 10. A Monosomic Plant . 231 II. New Telocentrics and Isochromosomes . .233 12. The Origin of lsochromosomes . .237 13. Pollen-Grain Inheritance . .239 14. The Future of lsochromosomes . .240 IS. The Evolution of Chromosome Numbers . 241 16. Conclusions . .242 17. Summary . 243 18. References . .246 Appendix: Compound Constrictions by L. F. La Cour 243 I. INTRODUCTION INour first account of ring formation in Campanula persicfo1ia (Gairdner and Darlington, 1931)weshowed how mechanical rules could be applied for the construction of plants with large rings at meiosis by the combination of interchanged chromosomes found in wild races. In our second account (Darlington and Gairdner, 1937)weshowed how large rings were maintained by the elimination of homozygotes but broke down more frequently than those stabilised by natural selection in Oenothera, owing to the occurrence of crossing-over between interstitial segments in opposite complexes. We also showed the high degree of structural hybridity in regard to inversions which was correlated with interchange hybridity in a cross-fertilising species. Our present object is to make use of the interchanges and other break- ages as markers in determining how hybridity is maintained by selection in the species, in other words how the breeding system works.
    [Show full text]
  • Epigenetic Control of Mammalian Centromere Protein Binding: Does DNA Methylation Have a Role?
    Journal of Cell Science 109, 2199-2206 (1996) 2199 Printed in Great Britain © The Company of Biologists Limited 1996 JCS3386 Epigenetic control of mammalian centromere protein binding: does DNA methylation have a role? Arthur R. Mitchell*, Peter Jeppesen, Linda Nicol†, Harris Morrison and David Kipling MRC Human Genetics Unit, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK *Author for correspondence (internet [email protected]) †Present address: MRC Reproductive Biology Unit, Edinburgh, UK SUMMARY Chromosome 1 of the inbred mouse strain DBA/2 has a block of minor satellite DNA sequences on chromosome 1. polymorphism associated with the minor satellite DNA at The binding of the CENP-E protein does not appear to be its centromere. The more terminal block of satellite DNA affected by demethylation of the minor satellite sequences. sequences on this chromosome acts as the centromere as We present a model to explain these observations. This shown by the binding of CREST ACA serum, anti-CENP- model may also indicate the mechanism by which the B and anti-CENP-E polyclonal sera. Demethylation of the CENP-B protein recognises specific sites within the arrays minor satellite DNA sequences accomplished by growing of minor satellite DNA on mouse chromosomes. cells in the presence of the drug 5-aza-2′-deoxycytidine results in a redistribution of the CENP-B protein. This protein now binds to an enlarged area on the more terminal Key words: Centromere satellite DNA, Demethylation, Centromere block and in addition it now binds to the more internal antibody INTRODUCTION A common feature of many mammalian pericentromeric domains is that they contain families of repetitive DNA The centromere of mammalian chromosomes is recognised at sequences (Singer, 1982).
    [Show full text]